Source: BioPortfolio

Rapamycin: Rapamycin Holdings Inc. Rebrands to Emtora Biosciences as New Leadership Focuses Company on Next Steps

Rapamycin Holdings Inc. RHI a privatelyheld emerging life science company based in San Antonio Texas has launched a new corporate brand Emtora Biosciences and brought on Dr. Carole Spangler Vaughn as its new CEO. The t...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Dan Hargrove's photo - President & CEO of Rapamycin

President & CEO

Dan Hargrove

CEO Approval Rating

77/100

Read more